cartilage defects osteochondral defects
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients that were treated for an osteochondral defect of the talus by means of 2-portal hindfoot approach in the AMC from 1988 until 2012 - Capable of filling out a questionnaire - Signed informed consent
Exclusion criteria
Exclusion criteria: - Systemic disease (e.g. rheumatoid arthritis, lupus erythematosus) - Ankle trauma 6 months or less prior to follow-up - Painful or invalid disorder of the lower extremity - Inability to understand the patient information and the questionnaires (e.g. mental retardation, language barrier) - No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The goal of this study is to evaluate the treatment. The primary outcome measure is the subjective outcome of the patients, measured by the Berndt & Harty Outcome score, and the Ogilvie-Harris score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are the VAS pain score at rest, during walking, and during running, the AOFAS score, the SF-36, the Berndt & Harty classification of osteochondral defects of the talus and the osteoarthritis classification previously published by Van Dijk et al. | — |
Countries
Netherlands